CII
AGN

CR Intrinsic Investors’s Allergan Inc AGN Stock Holding History

CR Intrinsic Investors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-268,000
Closed -$24.2M – 469
2013
Q3 		$24.2M Buy
+268,000
New +$24.1M 0.75% 26

Other funds holding AGN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 17.47% 1-Year Est. Return

CR Intrinsic Investors's AGN Position: Q4 2013 in Review

CR Intrinsic Investors sold out of Allergan Inc (AGN) in Q4 2013, closing a stake of 268,000 shares — an estimated $24.2M sold.

CR Intrinsic Investors first reported a position in AGN in Q3 2013 and held it in 1 quarter. The position peaked at $24.2M in Q3 2013. 709 funds tracked by Wall St. Rank hold AGN as of Q4 2013.

  • CR Intrinsic Investors reported no remaining Allergan Inc position as of Q4 2013 after selling out during the quarter.
  • CR Intrinsic Investors sold 268,000 Allergan Inc shares in Q4 2013, an estimated $24.2M.
  • CR Intrinsic Investors first reported a position in Allergan Inc in Q3 2013 and held it in 1 quarter.
  • CR Intrinsic Investors's Allergan Inc position peaked at $24.2M in Q3 2013.
  • 709 funds tracked by Wall St. Rank held Allergan Inc as of Q4 2013.

Based on CR Intrinsic Investors's 13F filing for Q4 2013, filed 14 Feb 2014.